Eris Lifesciences has informed that the Board of Directors of the Company at their meeting held today, 28th January 2021 duly approved and took on record the limited reviewed Un-audited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December 2020. The company has enclosed Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2020 along with the Limited Review Reports of the Auditors. The meeting of the Board of Directors commenced at 11:30 a.m. and concluded at 12:17 pm.
The above information is a part of company’s filings submitted to BSE.
